2012 Economic Outlook - Report Highlights Halozyme Therapeutics, Inc. and Masimo Corporation
(firmenpresse) - HONG KONG -- (Marketwire) -- 02/27/12 -- Today, announced new reports highlighting Halozyme Therapeutics, Inc. (NASDAQ: HALO) and Masimo Corporation (NASDAQ: MASI). Gain market insight with full analysis and research downloads available at .
Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.
Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.
Brighton Markets is releasing new coverage on Halozyme Therapeutics, Inc. for its current position within the healthcare industry. Halozyme Therapeutics, Inc. is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets. The full research report on Halozyme Therapeutics, Inc. (NASDAQ: HALO) is available here: .
Brighton Markets has released research on Masimo Corporation for its changing role within the healthcare industry. Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive patient monitoring products. It develops, manufactures and markets a patient monitoring solution that incorporates a monitor or circuit board and sensors, including single-patient use, reusable and ReSposable sensors and patient cables. The full research report on Masimo Corporation (NASDAQ: MASI) is available here: .
About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.
Contact:
Jean Barnes
email
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 27.02.2012 - 14:00 Uhr
Sprache: Deutsch
News-ID 118807
Anzahl Zeichen: 0
contact information:
Town:
HONG KONG
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 149 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"2012 Economic Outlook - Report Highlights Halozyme Therapeutics, Inc. and Masimo Corporation"
steht unter der journalistisch-redaktionellen Verantwortung von
Brighton Markets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
